| PERIOD ENDING | 31-Dec-08 | 31-Dec-07 | 31-Dec-06 | | Total Revenue | 6,262,305 | 6,129,795 | 5,730,018 | | Cost of Revenue | 2,978,331 | 2,870,755 | 2,640,327 | | | Gross Profit | 3,283,974 | 3,259,040 | 3,089,691 | | | Operating Expenses | | Research Development | 205,620 | 185,665 | 165,368 | | Selling General and Administrative | 1,948,473 | 1,907,160 | 1,764,260 | | Non Recurring | 200,254 | 264,013 | 35,999 | | Others |
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
| | | | Operating Income or Loss | 929,627 | 902,202 | 1,124,064 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 12,893 | 9,049 | 18,844 | | Earnings Before Interest And Taxes | 942,520 | 911,251 | 1,142,908 | | Interest Expense | 229,343 | 250,540 | 228,418 | | Income Before Tax | 713,177 | 660,711 | 914,490 | | Income Tax Expense | 244,929 | 280,222 | 335,004 | | Minority Interest | (20,755) | (19,242) | (13,827) | | | | Net Income From Continuing Ops | 447,493 | 361,247 | 565,659 | | | Non-recurring Events | | Discontinued Operations | (27,700) | 5,534 | (460,312) | | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | 419,793 | 366,781 | 105,347 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $419,793 | $366,781 | $105,347 |
|
1.52% Nasdaq 0.00%
Income Statement
